Subcutaneous Vedolizumab Appears to Be Effective Maintenance Therapy in Crohns Disease
NEW YORK (Reuters Health) – Subcutaneous vedolizumab appears to be an effective and safe maintenance therapy for some patients with
Read moreNEW YORK (Reuters Health) – Subcutaneous vedolizumab appears to be an effective and safe maintenance therapy for some patients with
Read more